1. Cates, W., Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex. Transm. Dis., 1999. 26: S2-S7.

2. World Health Organization, An overview of selected curable sexually transmitted diseases. Global Prog. on AIDS, 1995: 2-27.
3. CDC, 1998 Guidelines for Treatment of Sexually Transmitted Diseases. MMWR, 1998. 47(RR-1): 1-118.
4. Lossick, J. G. (1982). “Treatment of Trichomonas vaginalis infections.” Rev Infect Dis. 4: S801-818.
5. Petrin D., et. al. (1998). “Clinical and Microbiological Aspects of Trichomonas vaginalis.” Clinical Microbiology Reviews 11(2): 300-317.
6. Bowden, F.J. and G.P. Garnett, Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions. Sex Transm Infect, 2000. 76(4): 248-56.
7. World Development Report, World Bank, 1993.
8. Garnett, G.P. and F.J. Bowden, Epidemiology and control and curable sexually transmitted diseases: opportunities and problems. Sex. Transm. Dis., 2000. 27(10): 588-99
9. Bowden, F.J. and G.P. Garnett, Why is Trichomonas vaginalis ignored? Sex Transm Infect, 1999. 75(6): 372-4.
10. Ohlemeyer, C.L., et al., Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV culture versus wetmount microscopy. J. Adolesc. Health., 1998. 22: 205-208.
11. Cleveland, A., Vaginitis: finding the cause prevents treatment failure. Cleve Clin J Med, 2000. 67(9): 634-646.
12. Wiese W. et al,, A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am. J. Med., 2000. 108: 301-8.
13. Mohamed O.A. et al, Urine proves a poor specimen for culture of Trichomonas vaginalis in women. Sex Transmitted Infect., 2001. 77 (1): 78-9.
14. Ward, J.N., Trichomonal urethritis in the male. Mod Treat, 1970. 7(5): 1015-6.
15. Krieger, J. N. (2000). “Consider diagnosis and treatment of trichomoniasis in men.” Sex Transm Dis 27(4): 241-2.
16. Egan, M.E. and M.S. Lipsky, Diagnosis of vaginitis. Am Fam physician, 2000. 65(5): p. 1059-1104.
17. Mason, P.R., Trichomoniasis. New ideas on an old disease. S. Afr. Med. J., 1980. 58(21): 857-9.
18. Over, M. and P. Piot, Infection and STDs: Disease control priorities. World Bank Publication, 2000.
19. Buve, A., et al, The epidemiology of trichomoniasis in women in four African cities. Aids 2001. 15(S): 89-96.
20. Sorvillo, F., et al ., Trichomonas vaginalis, HIV and African-Americans. Emerging infectious diseases, 2001. 7(6): 927-932.
21. Wasserheit, J.N., Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Trans. Dis., 1992. 19: 61-77.
22. Fleming, D.T. and J.N. Wasserheit, From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Inf.,
1999. 75: 3-17.
23. Viikki, M., et al., Gynalogical infections as risk determinants of subsequent cervical neoplasia. Acta Oncol, 2000. 39(1): 71-75.
24. Yap, E.H., et al., Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients. Genitourin Med, 1995. 71(6): 402-4.
25. Zhang, Z.F., et al., Trichomonas vaginalis and cervical cancer. A prospective study in China. Ann Epidemiol, 1995. 5(4): 325-32.
26. Berggren, O., The incidence of Trichomonas vaginalis in cases of pre-invasive and invasive cervical cancer. Relationship between cervical cancer and Trichomonas vaginalis. Lakartidningen, 1967. 64(34): 3335-40.
27. Boyle, C.A., et al., Cervical intraepithelial neoplasia among women with papillomavirus infection compared to women with Trichomonas infection. Cancer, 1989. 64(1): 168-72.
28. Misra, J.S., K. Das, and Chandrawati, Results of clinically downstaging cervical cancer in a cytological screening programme. Diagn. Cytopathol., 1998. 19 (5): 344-8
29. Schachter, J., Sexually transmitted infections and cervical atypia. Sex. Transm. Dis., 1981. 8 (4 suppl): 353-6.
30. Slattery, M.L., et al., Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. Am. J. Epidemiol., 1989. 130(2): 248-58.
31. Cotch, M.F., J.G. Patorek, and R.P. Nugent, "Trichomonas vaginalis associated with low birth weight and preterm delivery." Sex. Transm. Dis., 1997. 24: 353-360.
32. El-Shazly, A. M., H. M. El-Naggar, et al. (2001). "A study on Trichomonas vaginalis and female infertility." J Egypt
33. Grodstein, F., M. B. Goldman, et al. (1993). "Relation of tubal infertility to history of sexually transmitted diseases." Am J Epidemiol 137(5): 577-84.
34. Sherman, K. J., J. R. Daling, et al. (1987). "Sexually transmitted diseases and tubal infertility." Sex Transm Dis 14(1): 12-6. Soc Parasitol 31(2): 545-53.
35. Kiviat, N. B., J. A. Paavonen, P. Wolner-Hanssen, C. W. Critchlow, W. E. Stamm, J. Douglas, D. A. Eschenbach, L. A. Corey, and K. K. Holmes. 1990. Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae. Hum. Path. 21: 831-837.
36. Hobbs, M. M., P. Kazembe, A. W. Reed, W. C. Miller, E. Nkata, D. Zimba, C. C. Daly, H. Chakraborty, M. S. Cohen, and I. Hoffman. 1999. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex. Transm. Dis. 26: 381-387.


Copyright ©2002 Xenotope Diagnostics Incorporated. All rights reserved.